Alzheimer's disease (AD) is a debilitating neurological disorder, and currently, there is no
cure for it. Several pathologic alterations have been described in the brain of AD patients …

BackgroundDementia with Lewy bodies (DLB) is increasingly recognized as a common
cause of dementia in older people. However, its true frequency remains unclear, with …

The broad importance of dementia is undisputed, with Alzheimer's disease justifiably getting
the most attention. However, dementia with Lewy bodies and Parkinson's disease dementia …

BackgroundPopulation-based prevalence and incidence studies are essential for
understanding the societal burden of dementia with Lewy bodies (DLB). MethodsThe …

Objective: To determine whether adding REM sleep behavior disorder (RBD) to the
dementia with Lewy bodies (DLB) diagnostic criteria improves classification accuracy of …

Background Alzheimer's disease (AD) is a neurodegenerative disorder that affects over 45
million people worldwide. Patients with severe AD require help with daily activities and show …

Objective To characterise the differences in caregiver distress between carers of people
diagnosed with dementia with Lewy bodies (DLB) and people with Alzheimer's disease …

Objective To synthesize the evidence across longitudinal studies comparing survival in
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Methods We conducted a …

The British Association for Psychopharmacology (BAP) coordinated a meeting of experts to
review and revise its first (2006) Guidelines for clinical practice with anti-dementia drugs. As …

Objective Neuropsychiatric symptoms (NPS) in dementia are frequent and challenging for
patients, carers, and the health care system, but few long‐term studies exist. We analyse the …